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Abstract 
 
 Acetylcholinesterase (AChE) is an essential enzyme required by the human body. It hydrolyzes 
the neurotransmitter acetylcholine (ACh) into two products, choline and acetate, at neurosynaptic 
junctions. Organophosphorous (OP) nerve agents such as sarin, tabun, and VX are covalent inhibitors 
of AChE. After a period of time that varies with each OP compound, the inhibition of AChE becomes 
irreversible due to aging, which is when a de-alkylation of the OP compound in the AChE active site 
occurs. This aging process results in ACh accumulation in the peripheral and central nervous system. 
While current pharmaceuticals containing an oxime functional are used to reverse inhibition of AChE 
by OP compounds, they are not effective in reversing inhibition of AChE after the OP compound has 
aged. A lack of pharmaceuticals to reverse this pathological aged state was the subject of intense 
research in the early 1970s, but quickly came to a halt due to the limitations of technology during that 
era. Now, with far more powerful technology and computational algorithms, research into drug 
discovery to reactivate aged AChE can be more efficient and effective. The focus of our research is to 
reactivate aged AChE. Previous reports from the literature demonstrated the capability of Quinone 
Methides (QMs) to alkylate phosphodiesters and other biological molecules. As a result, this class of 
compounds has the potential to reverse the aging process and restore function to aged AChE by 
alkylating the phosphonylated Serine-203 residue in the aged AChE active site. Using the 
computational methods of Molecular Docking and Molecular Dynamics, a library of Quinone Methide 
Precursors (QMPs) were tested and evaluated to determine which compounds from the library spent 
the most time in the aged AChE active site. Additionally, other residues of interest in the active site 
were examined with the goal of steering design efforts to produce QMPs that have a higher likelihood 
of potential alkylation. 
 
 
ii 
 
Acknowledgements 
 
 Throughout my time spent at Ohio State, I have met many individuals who have influenced the 
course of my life significantly enough to warrant mention in this section. Unfortunately only a few will 
be mentioned; however, I extend my gratitude and appreciation to all – listed or unlisted. 
 Firstly, I would like to extend my gratitude to Dr. Jeffery Turner for instilling a love of 
chemistry into a highly impressionable twenty-something. As a result of his influence, I explored 
research opportunities in the field of organic chemistry and found an opening with a new tenure-track 
faculty member… 
 Who happened to be Dr. Ryan J. Yoder, my current research advisor. I would like to thank 
Ryan for imparting some of his computational chemistry knowledge onto me, as well as for going 
above and beyond the call of an advisor. Many times, adversity strikes when one is on the cusp of 
achieving something great. To Ryan, this adversity was always an indication to overcome and advance 
through in order to reap the rewards that often lie on the other side of struggle. For that, a debt of 
gratitude is owed. Thank you for believing in me. 
 I would also like to thank Dr. Christopher Callam for his support, guidance, sharp wit, and 
excellent sense of humor. Never doubt the power of a good joke (or five.) 
 I must also thank Dr. Christopher Hadad for using the depth and breadth of his knowledge to 
help drive the project forward at critical crossroads. Without him, I feel that this thesis may never have 
been conceptualized. For that, I thank you greatly. 
I find it necessary to thank The Ohio State University at Marion for providing the opportunities 
to explore a breadth of subjects and meet the faculty who teach them. Providing those opportunities 
allowed me to meet and learn from the following staff and faculty who have forever positively 
impacted my life: Dr. John Emens, Dr. Robert Klips, Dr. Gary Maul, Professor Emeritus Dr. Brian 
McEnnis, Dr. Donna Bobbitt-Zeher, Dr. John Maharry Dr. Zakaria Nyongesa, Dr. Chris and Amy 
iii 
 
Friesen, Dr. Ben McCorkle, Dr. Terry Pettijohn, Dr. Daniel Wojta, Dr. Christopher Daddis, Dr. Nikole 
Huffman, Leslie Beary, Lynda Behan, and the staff of Maynard Hall. Sometimes, pleasant 
conversation and smiling faces are what will take you the distance. Thank you for everything. 
Lastly, I would like to thank my friends, family, and those I care deeply about for supporting 
me during my time as an undergraduate and throughout the medical school application process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
List of Figures 
 
Figure              Page 
 
Figure 1.1. Structures of OPs used as chemical warfare agents along with less toxic pesticides, amiton 
and paraoxon.. ........................................................................................................................................... 1 
Figure 1.2. The use of QMPs to reactivate aged AChE in order to reverse the aging process of the 
enzyme upon exposure to nerve agents. ................................................................................................... 3 
Figure 2.1. Initial Library of Quinone Methide Precursor Compounds ................................................... 6 
Figure 2.2. Compound E interacting with residues of interest within AChE ......................................... 16 
Figure 2.3. A second view of Compound E interacting with residues of interest within AChE ............ 17 
Figure 2.4. A third view of Compound E interacting with residues of interest within AChE. .............. 18 
Figure 3.1. QMP Structures used as base scaffolds for an expanded library of new variants ................ 21 
Figure 3.2. Second Library of Compounds ............................................................................................ 22 
Figure 3.3 Second Library of Compounds ............................................................................................. 23 
Figure 3.4 Second Library of Compounds ............................................................................................. 24 
Figure 3.5 Second Library of Compounds ............................................................................................. 25 
Figure 3.6. Compounds with highest active site affinity ........................................................................ 29 
Figure 3.7. Compounds with lowest active site affinity ......................................................................... 30 
Figure 4.1. Compound A3DM with its dimethylammonium leaving group sitting close to W86. ........ 33 
Figure 4.2. Compound A3PYM with its pyrrolidine leaving group sitting further from W86 and closer 
to Ser203. ................................................................................................................................................ 34 
Figure 4.3. An illustration of the interactions between a +2 Protonation State Methylpyridinium QMP 
and W86, Y124, and Ser203. .................................................................................................................. 35 
Figure 4.4. Compound A3MN, its unprotonated leaving group, and identification of interactions which 
might facilitate its poor affinity for the active site. ................................................................................ 36 
v 
 
List of Tables 
 
Table                         Page
  
 
Table 2.1. Molecular Docking Results for First Library ........................................................................ 10 
 
Table 2.2. AChE Zones (All bounds closed except “Between AS and BN” and “Other”) .................... 13 
 
Table 2.3. MD Results for First Library ................................................................................................. 14 
 
Table 2.4. MD Statistics Measuring Distance between Phosphonate Oxygen and QMP Benzylic 
Carbon for First Library .......................................................................................................................... 14 
 
Table 3.1. MD Results for Second Library............................................................................................. 29 
 
Table 3.2. MD results for compounds with highest active site affinity (high to low) ............................ 30 
 
Table 3.3. MD results for compounds with lowest active site affinity (low to high) ............................. 31 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
Table of Contents 
Abstract ...................................................................................................................................................... i 
Acknowledgements ................................................................................................................................... ii 
List of Figures ........................................................................................................................................... ii 
List of Tables  ........................................................................................................................................... v 
1. Introduction ........................................................................................................................................... 1 
1.1 OP Exposure and the Role of Quinone Methides as Potential Therapeutic Agents .................. 1 
1.2 References .................................................................................................................................. 5 
2. Initial Library ........................................................................................................................................ 6 
2.1     Introduction ................................................................................................................................. 6 
2.2     Preparation of Compounds for Molecular Docking .................................................................... 7 
2.3     Molecular Docking ..................................................................................................................... 8 
2.4     Molecular Docking Results ....................................................................................................... 10 
2.5     Molecular Dynamics ................................................................................................................. 12 
2.6     Molecular Dynamics Results .................................................................................................... 14 
2.7     Compound E Analysis .............................................................................................................. 16 
2.8     References ................................................................................................................................. 20 
3. Second Library .................................................................................................................................... 21 
3.1 Introduction .............................................................................................................................. 21 
3.2 Molecular Dynamics Results ................................................................................................... 27 
3.3 References ................................................................................................................................ 32 
4. Conclusions and Future Work ............................................................................................................ 33 
4.1 Conclusions .............................................................................................................................. 33 
4.2 Future Work ............................................................................................................................. 37 
1 
 
1. Introduction 
 
1.1 OP Exposure and the Role of Quinone Methides as Potential Therapeutic Agents 
 Organophosphorus compounds (OPs) are a class of compounds that contain a phosphoryl 
group. Their origin lies in the development of pesticides, when tabun was accidentally 
discovered by Dr. Gerhard Schrader in Germany in 1936.1 This extreme toxicity to human life 
did not go unnoticed, leading to tabun’s development into a potential chemical weapon.2 Since 
then, many more OP compounds have been created. Of these, the most frequently recognized 
compounds are sarin (GB), soman (GD), and VX (Figure 1.1). 
 
Figure 1.1: Structures of OPs used as chemical warfare agents along with less toxic pesticides, 
amiton and paraoxon. 
 
In recent history, these OP compounds have been used on military and civilian 
populations in several countries. Between the months of April and July 1988, the Iraqi army led 
by Saddam Hussein launched several rockets containing OP nerve agent near the towns of al-
Faw, Mehran, and Dehloran in Iraq, killing hundreds to thousands of Iranian solders.3  In 1995, 
sarin gas was released into the Japanese subway system by Aum Shinrikyo, a terrorist 
organization. At least 7 people died and thousands more were hospitalized by the exposure.4 On 
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August 21st 2013, the Syrian government launched rockets with sarin-containing warheads into 
suburbs of Damascus.5 While there is no official death toll, Médecins Sans Frontières (Doctors 
Without Borders) has said that at least 3,600 civilians were treated for symptoms consistent with 
sarin poisoning - vomiting, respiratory issues, and kidney failure at the area’s three hospitals 
within 3 hours of the attack.6 Records collected by Human Rights Watch show that 734 civilians 
in the suburb of Zamalka died as a result of the sarin gas attacks, with most victims being 
children.7 With casualties primarily being civilians, there has never been a greater need to 
develop treatments for OP exposure. 
 OP nerve agents are neurotoxins that are extremely potent. They owe their biological 
activity to their ability to inactivate the catalytic triad found in acetylcholinesterase (AChE), an 
enzyme that hydrolyzes the excitatory neurotransmitter acetylcholine. This catalytic triad 
consists of Ser-His-Glu residues found in the active site. The serine residue of this triad is 
modified by OPs after they covalently bind to it, effectively inhibiting the enzyme's function. At 
this time, the treatment protocol for OP exposure is the concurrent administration of 2-
Pralidoxime (2-PAM), atropine, and diazepam (Valium) to exposed individuals. 2-Pralidoxime 
(2-PAM) is a strong nucleophile capable of displacing the OP moiety from the OP-AChE 
complex. It is the powerhouse of this protocol that restores catalytic function to the inhibited 
enzyme. If untreated, the OP-AChE complex can undergo a process called aging, where the OP 
compound is dealkylated.8 This aging process leaves only the OP’s phosphate group attached to 
the serine residue, irreversibly inhibiting the AChE enzyme (Figure 1.2). The speed at which 
aging occurs depends solely on the OP compound being used9; regardless, the outcome of aging 
is irreversible inhibition of AChE. After aging occurs, there are no pharmaceuticals currently in 
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existence that are capable of displacing the OP moiety. The lack of therapeutic agents to reverse 
the dealkylation of aged AChE is the focus of our research. 
 Quinone Methides (QMs) are high-energy electrophiles that are used in important 
biological processes, like lignin biosynthesis in plants, DNA alkylation, and cross-linking of 
structural proteins.10,11 The motivation to explore this class of compounds towards reversing the 
aging process of OP-inhibited AChE comes from two studies. The first, a study from Modica et 
al.12, determined that QMPs had the ability to alkylate many nucleophiles, specifically amino 
acids. The second study, from Bakke et al.13 reported that QMPs can re-alkylate phosphodiesters 
in aqueous conditions. The ability of QMP compounds to re-alkylate phosphodiesters and amino 
acids encourages us in the pursuit of these compounds as a solution to reversing aged AChE, 
because the OP compounds inhibiting AChE form a phosphodiester bond with the serine residue 
which results in the OP-AChE complex. 
 
Figure 1.2: The use of QMPs to reactivate aged AChE in order to reverse the aging process of 
the enzyme upon exposure to nerve agents. 
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 Due to the sheer number of QMPs that could be created, a high-throughput process was 
required to narrow down the potential candidates for laboratory testing. As a result, 
computational methods were employed to guide synthetic efforts to produce a QMP that was 
selective and specific for the active site of AChE. 
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2. First Library 
2.1 Introduction 
 An initial library of seven para-Quinone Methide Precursors (p-QMPs) (Figure 2.1) was 
produced during discussion with collaborators. These seven compounds use vanillin as a 
scaffold, where variations between them are the result of group substitutions at only the phenolic 
position. Compound E represents this base vanillin scaffold. For the amine leaving group, each 
QMP was held constant using dimethyl ammonium. 
 
 
Figure 2.1: Initial Library of Quinone Methide Precursor Compounds 
 
 
 
 
 
 
7 
 
2.2 Preparation of Compounds for Molecular Docking 
 In order to dock these compounds into the active site of aged AChE, they first required 
preparation in order to provide meaningful results. Initially, all seven p-QMPs were built in 
GaussView 4.1.21. Several different conformations of each compound were manually generated 
by altering bond angles and distances in order to give a best attempt at discovering each 
compound’s global energy minimum. Then, all seven compounds and their alternate 
conformations were optimized with Gaussian 092 using the B3LYP/6-311+G** level of theory 
with a Polarizable Continuum Model3 of Solvation of water. After the optimizations, the lowest 
energy conformation for each compound was determined and underwent vibrational frequency 
analysis at B3LYP/6-311+G** to look for the absence of imaginary frequencies, which would 
confirm that the geometry was a minimum on the potential energy surface. After confirmation of 
the absence of imaginary frequencies, then Merz-Kollman charge calculations were performed at 
the B3LYP/6-311+G** level of theory on each compound’s lowest energy conformation to 
complete their preparation for molecular docking. 
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2.3 Molecular Docking 
 Molecular Docking is a computational technique that can give insight into the possible 
orientations of ligands inside receptors by examining the electrostatic interactions between the 
two. Typically, the ligand is treated as flexible with no rotational or torsional restrictions whereas 
the receptor is treated as rigid and no torsion or rotation is permitted. For this research, p-QMPs 
were docked inside the active site of thirteen snapshots of artificially aged human 
acetylcholinesterase (AChE). The thirteen artificially aged AChE snapshots (frames) were 
produced by Dr. Jeremy Beck as a portion of his dissertation.4 The frames are stills taken from a 
5 nanosecond molecular dynamics simulation of aged AChE with a generic QMP in the active 
site. The benefit of using these frames for our docking calculations is that induced fit effects on 
AChE from QMPs could be considered while still being able to treat AChE as rigid, which has a 
lower computational cost. Dr. Jeremy Beck sourced the structure of AChE from an available 
crystal structure in the Protein Data Bank (PDB id 1B415). He removed waters, cofactors, and an 
associated fasciculin-II peptide using UCSF Chimera.6 He then restored any missing residues 
using electric ray AChE homology (PDB id 1C2B7) and then added a phosphonate to the 
catalytic Serine-203 residue (Ser203) in order to produce human aged AChE. 
 For the molecular docking simulations on these seven compounds, all compounds were 
docked into each of the 13 receptor frames using Autodock 4.0.8 A 50 x 50 x 50 Å3 grid box was 
produced and centered at a moiety known as the oxyanion hole in order to limit the calculation to 
the active site and associated gorge to reduce computational expense. For each compound, 200 
poses (snapshots of the compounds inside AChE) were generated for every receptor frame. This 
resulted in a total of 2600 poses per compound. 
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After completion of the molecular docking simulations, the positioning of these 
compounds within aged AChE was evaluated. Each docking simulation output contained 200 
poses organized in a histogram from lowest binding energy to highest. The histogram associated 
poses with very similar binding energies into one bin. Each bin was examined and the distance 
measured for every pose within it. A bin with 75% or more of its poses falling into one of the 
three categories, which will be explained below had all of its poses designated as that category. 
This reduced the amount of manpower hours necessary to score each compound. Lastly, the 
poses associated with each category were summed and divided by the total number of poses per 
compound to give percentages. 
Each pose was evaluated and classified into two categories: “within 3.7 Å” and “other”. 
A “within 3.7 Å” pose was considered to be one that had a distance equal or less than 3.7 Å 
between the p-QMP benzylic carbon and phosphonate oxygen on Ser203. An “other” pose 
covers any pose that has a benzylic carbon to phosphonate oxygen distance greater than 3.7 Å. A 
sub-category of “within 3.7 Å”, titled “within 3.7 Å, reactive orientation” was created to describe 
poses satisfying the distance requirement but also having the QMP’s amine leaving group 
oriented away from the phosphonylated serine oxygens. This orientation would result in minimal 
steric interference if the desired alkylation reaction were to occur via SN2 direct displacement. 
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2.4 Molecular Docking Results 
 After completing the manual scoring process as outlined in Section 2.3, a table of the 
results was produced (Table 2.1). 
 
Compound Within 3.7 Å, reactive 
orientation (%) 
Within 3.7 Å, 
unreactive orientation 
(%) 
Other (%) 
A 31.9 4.6 63.5 
B 37.4 15.9 46.7 
C 29.7 30.3 40 
D 23.2 40.9 35.9 
E 17.6 28.3 54.1 
F 15.6 43.3 41.1 
G 38.8 11.1 50.1 
Table 2.1: Molecular Docking Results for First Library 
 
 
Of these seven compounds, those with the highest proportion of poses within 3.7 Å were C, D, 
and F, which have fluorine, no functional, and acetal substitutions at the phenolic position, 
respectively. This was a rather interesting finding, as A, E, and G are the three worst performing 
compounds by this same metric and chemical intuition suggests that these compounds might 
preferentially undergo an SN1 dissociation rather than a direct displacement reaction. 
Additionally, A, E, and G had the highest percentages of their poses exceeding 3.7 Å in distance 
between their benzylic carbons and the phosphonylated serine oxygens. Further experimental 
data regarding these ligands and enzyme itself would be ideal so that plausible, meaningful 
explanations of these trends are better supported. Therefore, Molecular Dynamics simulations 
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were performed on the library of seven compounds to simulate the interactions between the 
ligands and the aged AChE active site and obtain more information. 
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2.5 Molecular Dynamics (MD)       
 Molecular Dynamics is a computational method that permits one to simulate how a 
ligand might interact with a receptor or other molecule in a variety of solvents (or the gas phase) 
over time. In this calculation, both the ligand and the enzyme are treated as flexible, which 
permits a better approximation than molecular docking of what could be happening on an atomic 
level during experiments. For this application, the three lowest energy clusters from the previous 
molecular docking calculations were used as input geometry for the MD simulations. These input 
geometries placed the p-QMPs at varying distances from the phosphonylated serine residue 
within AChE’s active site. All 13 prepared aged AChE receptor frames were used in these 
calculations, making a maximum total of 39 MD calculations per ligand. These were performed 
using the Sander module in AMBER11.9 The simulated system was neutralized with Na+ ions 
and solvated with explicit water. After this preparation, the simulated system underwent two 
minimizations. The first set of minimizations involved 500 steps of a calculation known as 
Steepest Descent Minimization10, where the overall energy of the system is pushed away from 
any local maxima as quickly as possible while permitting the calculations to have larger error in 
their approximations. Next, the simulated system underwent 500 steps of a calculation known as 
Conjugate Gradient Minimization10, which lowers the system’s energy at a much slower rate so 
that it can be approximated with more accuracy. This allows the system to be brought closer to 
its global minimum. For the second set of minimizations, the system underwent another 1000 
steps of Steepest Decent Minimization followed by 1500 steps of Conjugate Gradient 
Minimization. After these minimizations, the system was heated linearly from 0 Kelvin to 300 
Kelvin over 20 picoseconds (10,000 steps of 2 femtoseconds) at 1 atm. After heating, MD 
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calculations were performed on this system over 1 nanosecond (500,000 steps of 2 
femtoseconds). 
 After completion of the MD calculations, it became readily apparent that characterization 
of the enzyme AChE would be necessary in order to derive meaning from the results. For this 
characterization, the gorge to the active site of AChE was labeled based upon the distance 
between the phosphonate oxygens on Ser203 in the active site to certain residues in specific 
regions in the gorge (Table 2.2). 
 
Zone Distance from Ser203 
Active Site (AS) 0 - 5 Å 
Between AS and 
BN 5- 7 Å 
Bottleneck (BN) 7 - 9.5 Å 
Gorge Mouth 
(GM) 10 - 15 Å 
Other 15 Å+ 
 
Table 2.2: AChE Zones (All bounds closed except “Between AS and BN” and “Other”) 
 
 
 
 
 
 
 
14 
 
2.6 Molecular Dynamics Results 
 Using the previously defined zones (Table 2.3), a table of results was produced by 
measuring the distance between the benzylic carbon of each QMP and the phosphonylated Serine 
oxygens in the active site for every still frame in the MD calculation (500 per 1ns MD). Every 
still frame was classified as one of the five zones. After every still frame was classified (using 
Excel  Filter) a fraction of the total number of still frames per ligand (typically 19500) was 
taken and a fraction of total poses present in a particular zone was then determined (Table 2.4). 
Name % Active Site % Between AS and BN % Bottleneck % Gorge Mouth % Other 
A 47.5 18.5 11.9 20.0 20.7 
B 44.3 22.6 9.2 22.2 24.3 
C 46.6 16.3 10.6 24.5 18.2 
D 45.8 27.2 7.1 18.1 29.0 
E 44.7 23.2 6.0 22.6 26.7 
F 58.2 12.9 10.4 16.6 14.8 
G 49.8 10.9 14.2 20.7 15.3 
Table 2.3: MD Results for First Library 
 
Compound Mean Median Mode Max Min 
A 6.45 5.18 3.30 15.46 2.77 
B 6.47 5.33 3.64 16.05 2.66 
C 6.83 5.19 5.41 15.65 2.73 
D 6.09 5.17 3.35 16.97 2.68 
E 6.63 5.18 6.66 16.00 2.73 
F 5.72 3.82 3.23 15.35 2.73 
G 6.62 5.02 3.28 15.22 2.78 
Table 2.4: MD Statistics Measuring Distance between Phosphonate Oxygen and QMP Benzylic 
Carbon for First Library 
 The 3 compounds with highest affinity for the active site after examining the MD results 
are A, F, and G. Compound F (acetal) also happens to be one of the best performers in the 
Molecular Docking studies. However, these MD results should be compared with Molecular 
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Docking results very carefully, as it is important to acknowledge that the upper boundary for the 
“active site” in MD is 5.0 Å, whereas that bound is 3.7 Å in Molecular Docking results. 
 Focusing back onto the MD results in Figure 2.4, a curious question is posed – why does 
Compound E (hydroxyl at the phenolic position) perform several percentage points lower than 
Compounds A and G, which should form the same QM intermediate if they undertake SN2 
dissociation? A closer look was taken at Compound E to suggest an explanation for the deviance. 
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2.7 Analysis of Compound E 
 In an attempt to understand the deviance from expected values, one MD video from each 
of the 13 receptor frames were viewed in an attempt to explain why this particular compound 
preferred to orient itself further away from the phosphonylated serine-203 residue (S203-OP 
adduct). 
 In most of the videos observed, the ligand (Compound E) was visualized interacting with 
Y124 and W86. Y124 is an aromatic residue (tyrosine) located in the Bottleneck zone. It is 
capable of hydrogen bond donation and acceptance, as well as cation-pi interactions. W86 is an 
aromatic residue (tryptophan) that is capable of only hydrogen bond acceptance and cation-pi 
interactions. Three labeled images (Figures 2.2, 2.3, and 2.4) are displayed below and explained.  
 
Figure 2.2: Compound E interacting with residues of interest within AChE 
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 The first image (Figure 2.2) suggests that the ligand Compound E’s hydroxyl group at the 
phenolic position may be involved in unique hydrogen bonding reciprocity with Y124 not 
demonstrated by the rest of the seven compounds. The image also suggests that cation-pi 
interactions between the dimethylammonium leaving group of the ligand and W86 may also play 
a role in tethering the ligand to residues outside of the upper bound for the active site. These 
residues and the suggested interactions are indicated in yellow. 
 
Figure 2.3: A second view of Compound E interacting with residues of interest within AChE 
 The second image (Figure 2.3) above does not show interactions between the ligand and 
Y124. However, it does imply hydrogen bond donation and cation-pi interactions between the 
ligand and W86. 
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Figure 2.4: A third view of Compound E interacting with residues of interest within AChE 
 The third view (Figure 2.7) suggests that hydrogen bonding reciprocity between Y124 
and the ligand are present, as well as the implication of potential cation-pi interactions with Y124 
from the ligand. In this third image, there are no interactions with W86. 
These three images highlight three different orientations of Compound E near AChE’s 
gorge bottleneck. They represent the majority of Compound E’s simulated interactions with the 
enzyme. The most plausible explanation of Compound E’s inferior performance in comparison 
to Compounds A and G is that the presence of a hydroxyl group at the phenolic position on 
Compound E allows it to both donate and accept hydrogen bonding with Y124. In combination 
with its protonated dimethylammonium leaving group permitting cation-pi interactions with 
residues near the active site, this added hydrogen bond acceptance-donor reciprocity uniquely 
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enables Compound E to select Y124 and reduce the amount of time it spends within the active 
site zone. 
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3. Second Library 
3.1 Introduction 
 After examination of the MD data shown in the previous chapter, three compounds with 
the highest affinity for the active site were selected as scaffolds to produce a new library of 
compounds to evaluate. An additional six compounds were selected from MD calculations 
performed by fellow undergraduates Keegan Fitzpatrick and Andrew Franjesevic on the same 
basis. Based on their origins, one letter codes were assigned to each compound to produce three 
“classes” of QMPs – T, A, and K (Figure 3.1).1 
 
 
Figure 3.1: QMP Structures used as base scaffolds for an expanded library of new variants. 
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After discussion with collaborators, two variations in the base scaffolds evaluated for 
their effects on active site affinity. The first variation was a substitution of the amine leaving 
group, substituting dimethylammonium with dimethylammonia, pyrrolidine, piperidine, or 
morpholine functionals. The second variation was a change in the protonation state of the leaving 
group and heterocyclic nitrogen (if applicable) to neutral, protonated, or methylated analogs. 
Using these variations, ninety-nine analogs were designed. From those, seventy-eight were 
selected for evaluation (Figure 3.2, 3.3, 3.4, 3.5) using the molecular docking and molecular 
dynamics procedures described in Chapter 2. The remaining compounds were given to fellow 
undergraduates to perform the same calculations.  
 
 
Figure 3.2: Second Library of Compounds 
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Figure 3.3: Second Library of Compounds 
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Figure 3.4: Second Library of Compounds 
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Figure 3.5: Second Library of Compounds 
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 The naming scheme for this library is relatively straightforward. As mentioned earlier in 
this chapter, the first two characters in the name indicate the class that the scaffold belongs to, 
and which specific scaffold was used. The remaining characters indicate which amine leaving 
group is present on the compound, followed by what the protonation state of the compound is. 
For leaving groups, dimethylammonia is indicated by D, pyrrolidine is indicated by PY, 
piperidine by PI, and morpholine by M. For protonation states, neutral is indicated by N, 
protonated by P, and methylated by M. The order of the codes is the same for every compound in 
this library. 
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3.2 Molecular Dynamics Results 
 Using the same zoning criteria from the previous chapter, tables of results were produced 
from the MD calculations (Table 3.1). 
Compound Name % Active Site % Between AS and BN 
% 
Bottleneck 
% Gorge 
Mouth % Other 
A1DN 20.88 35.66 26.87 11.95 4.65 
A1MN 21.31 32.82 30.84 12.32 2.72 
A1PIN 27.06 38.07 24.28 9.05 1.55 
A1PYN 37.10 31.64 22.59 5.23 3.45 
A2DN 36.77 25.85 18.70 13.95 4.73 
A2MN 9.12 29.42 22.55 33.19 5.71 
A2PIN 25.71 46.33 15.36 10.69 1.90 
A2PYN 30.37 40.46 20.32 6.39 2.45 
A3DN 40.58 27.17 23.42 7.01 1.82 
A3MN 11.68 42.33 25.32 17.29 3.38 
A3PIN 27.01 34.93 27.32 9.42 1.33 
A3PYN 30.39 31.36 28.09 9.23 0.93 
A1DM 37.54 32.41 7.22 17.64 5.20 
A1MM 45.72 15.71 2.74 30.65 5.17 
A1MP 41.15 23.10 5.49 25.79 4.48 
A1PIM 53.88 14.54 1.59 27.21 2.78 
A1PIP 67.66 14.06 2.78 8.20 7.30 
A1PYM 45.54 23.09 5.28 17.39 8.70 
A1PYP 65.76 16.43 1.76 9.59 6.46 
A2DM 61.47 10.11 5.42 14.83 8.17 
A2MM 21.48 36.23 11.69 25.11 5.49 
A2MP 49.66 16.47 7.37 20.21 6.29 
A2PIM 23.84 42.04 8.49 22.29 3.35 
A2PIP 57.36 21.55 7.86 7.04 6.18 
A2PYM 41.59 32.70 5.47 14.41 5.83 
A2PYP 62.85 17.58 1.95 13.38 4.24 
A3DM 73.75 5.21 3.53 13.46 4.05 
A3MM 24.64 18.00 9.15 39.31 8.89 
A3MP 40.97 15.79 9.92 28.71 4.60 
A3PIM 64.57 7.18 5.87 17.98 4.39 
A3PIP 68.51 6.51 4.83 15.31 4.85 
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Compound Name % Active Site % Between AS and BN 
% 
Bottleneck 
% Gorge 
Mouth % Other 
A1DM 37.54 32.41 7.22 17.64 5.20 
A1MM 45.72 15.71 2.74 30.65 5.17 
K1DN 44.44 23.06 16.73 10.52 5.25 
K1MN 28.85 41.55 16.21 9.14 4.25 
K1PIN 49.81 29.08 13.66 5.88 1.57 
K1PYN 41.57 33.18 15.70 8.22 1.33 
K2DN 29.86 25.24 21.72 17.98 5.20 
K2MN 24.16 29.72 20.76 21.82 3.53 
K2PIN 38.46 17.23 22.88 15.38 6.05 
K2PYN 34.83 32.55 16.02 12.76 3.85 
K3DN 34.32 22.46 34.33 6.82 2.07 
K3MN 17.82 34.34 25.76 16.90 5.18 
K3PIN 16.56 29.96 30.23 19.81 3.45 
K3PYN 25.36 30.37 31.24 10.87 2.16 
K1DM 63.06 7.36 2.48 16.23 10.87 
K1MM 36.54 17.38 2.66 37.17 6.24 
K1MP 53.95 12.46 7.29 16.71 9.59 
K1PIM 58.09 9.74 4.60 22.63 4.94 
K1PIP 56.53 17.83 4.93 16.76 3.94 
K1PYM 71.29 5.65 2.43 18.26 2.37 
K1PYP 68.65 10.57 2.00 15.33 3.45 
K2DM 42.06 20.92 5.51 21.01 10.51 
K2MM 44.92 18.35 1.93 28.52 6.28 
K2MP 40.17 14.75 3.41 27.74 13.93 
K2PIM 44.93 17.86 9.48 24.45 3.28 
K2PIP 67.17 8.26 4.04 15.23 5.31 
K2PYM 65.86 12.62 3.43 16.08 2.02 
K2PYP 56.40 9.46 6.00 23.10 5.04 
K3DM 55.48 15.09 6.81 18.42 4.21 
K3MM 35.37 12.06 7.23 37.23 8.11 
K3MP 42.07 18.10 0.78 28.78 10.27 
K3PIM 46.40 14.62 6.62 27.97 4.39 
K3PIP 56.53 8.39 3.68 15.76 15.63 
K3PYM 55.61 15.35 5.64 20.27 3.14 
K3PYP 64.69 15.78 4.70 9.04 5.78 
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Compound Name % Active Site % Between AS and BN 
% 
Bottleneck 
% Gorge 
Mouth % Other 
T1DM 50.4 14.1 11.0 20.7 3.8 
T1MM 25.7 18.1 23.2 29.0 4.0 
T1PIM 47.5 21.9 9.8 18.1 2.8 
T1PYM 44.3 11.6 18.2 23.8 2.0 
T2DM 51.7 8.3 12.3 20.9 6.9 
T2MM 25.4 15.2 25.0 31.3 3.2 
T2PIM 49.7 11.7 15.5 20.5 2.6 
T2PYM 54.7 20.5 9.3 13.8 1.7 
T3DM 63.2 9.5 8.5 14.2 4.5 
T3MM 30.0 11.9 19.6 34.0 4.5 
T3PIM 49.1 28.1 6.2 14.2 2.4 
T3PYM 35.3 36.2 6.9 17.8 3.8 
Table 3.1: MD Results for Second Library 
 
Of these seventy-eight compounds, ten compounds with the highest and lowest affinities 
for the active site were identified, and their data was assimilated (Figure 3.3, Table 3.2, Figure 
3.4, Table 3.3). 
 
Figure 3.6: Compounds with highest active site affinity 
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Compound Name % Active Site % Between AS and BN 
% 
Bottleneck 
% Gorge 
Mouth % Other 
A3DM 73.70 5.20 3.50 13.50 4.10 
A3PYM 71.40 4.60 1.90 17.60 4.50 
K1PYM 71.30 5.70 2.40 18.30 2.40 
K1PYP 68.60 10.60 2.00 15.30 3.50 
A3PIP 68.50 6.50 4.80 15.30 4.80 
A1PIP 67.70 14.10 2.80 8.20 7.30 
K2PIP 67.20 8.30 4.00 15.20 5.30 
K2PYM 65.90 12.60 3.40 16.10 2.00 
A1PYP 65.80 16.40 1.80 9.60 6.50 
T3DM 63.20 9.50 8.50 14.20 4.50 
Table 3.2: MD results for compounds with highest active site affinity (high to low) 
 
 
 
 
Figure 3.7: Compounds with lowest active site affinity 
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Compound Name 
% Active 
Site % Between AS and BN 
% 
Bottleneck 
% Gorge 
Mouth % Other 
A2MN 9.12 29.42 22.55 33.19 5.71 
A3MN 11.68 42.33 25.32 17.29 3.38 
K3PIN 16.60 30.00 30.20 19.80 3.40 
K3MN 17.80 34.30 25.80 16.90 5.20 
A1DN 20.88 35.66 26.87 11.95 4.65 
A1MN 21.31 32.82 30.84 12.32 2.72 
A2MM 21.50 36.20 11.70 25.10 5.50 
T2MM 25.40 15.20 25.00 31.30 3.20 
T1MM 25.73 18.06 23.22 28.99 4.00 
A2PIN 25.71 46.33 15.36 10.69 1.91 
Table 3.3: MD results for compounds with lowest active site affinity (low to high) 
  
 Comparing the ten compounds with highest active site affinity, it is readily apparent that 
the majority of these compounds had pyrrolidine and piperidine leaving groups. In fact, the only 
leaving group that did not have any representation in the top ten was morpholine.  All but one of 
the top performers had pyridinium or methylpyridinium cyclic units, with the compound falling 
into tenth place containing a phenyl ring. Additionally, all but one of the top performers had 
protonation states of +2 with a 5-to-4 split of methylation to protonation. 
 Looking at the ten compounds with the lowest active site affinity of the library, seven of 
the ten compounds had morpholine leaving groups, suggesting that morpholine’s absence from 
the highest affinity list is likely not a coincidence. Additionally, nine of the ten compounds had 
protonation states of +1. Most of these compounds have pyridinium or methylpyridinium rings, 
with a slightly larger proportion of the phenyl ringed vanillin compounds being present in this 
short list. 
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4. Conclusions and Future Work 
4.1 Conclusions 
 The data shows that the best performing leaving groups from the expanded library of 
seventy-eight were pyrrolidine and piperidine functional groups that also were protonated or 
methylated at the heterocyclic nitrogen. After observing MD simulation videos of these 
compounds, it was seen that because of the size of these leaving groups, they were not as close to 
W86 as the library of 7 dimethylammonium leaving group compounds were as discussed in 
Chapter 2 (Figure 4.1). While these larger leaving groups were still close enough to undergo 
cation-pi interactions, it appears that the conformation of those leaving groups prevented them 
from being flatter and therefore sitting closer to W86 (Figure 4.2). This inability to sit closely 
resulted in the benzylic carbon being closer in proximity to the Ser203 phosphonate oxygens, 
resulting in these compounds having better rankings. 
 
Figure 4.1: Compound A3DM with its dimethylammonium leaving group sitting close to W86. 
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Figure 4.2: Compound A3PYM with its pyrrolidine leaving group sitting further from W86 and 
closer to Ser203. 
 
 Additionally, it was found that having a +2 protonation state increased the probability 
that compounds would be among those with the most affinity for the active site. Having a 
protonated leaving group aids in anchoring the QMPs to W86 in the Cation Binding Pocket 
(CBP), bringing the QMP within 4-7 Angstroms of the Ser203 residue on a regular basis. 
However, it seems that because of the ortho and para orientations of the protonated or methylated 
heterocyclic nitrogen of the pyridinium cyclic units, these compounds are particularly suited to 
interact with W86 and Y124  to minimize their benzylic carbon’s distance to Ser203 over the 
source of an MD simulation (Figure 4.3). With less charged QMPs, they would typically bounce 
around within 3-6 Angstroms of their initial distance although sometimes movement between all 
3 zones could be visualized. With these +2 protonation state QMPs, the QMPs themselves 
bounced around 2-3 Angstroms of their original distance. It seems that having that additional 
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charge in the ring permits H-bond acceptance from Y124 as well as alternating cation-pi 
interactions between the protonated leaving group and the pyridinium unit, reducing the distance 
that these compounds will move when they are in the active site. 
 
Figure 4.3: An illustration of the interactions between a +2 Protonation State Methylpyridinium 
QMP and W86, Y124, and Ser203. 
 Regarding the compounds with the lowest active site affinity, a +1 protonation state and a 
morpholine leaving group were the most commonly observed variations. A compound that has 
only a protonated amine leaving group, using the hypothesis suggested above, should have more 
variance when interacting with W86 in the CBP. For one of the worst performing compounds 
A3MN, interactions with residues in the bottleneck zone were commonly observed (Figure 4.4). 
Seemingly, an unprotonated amine leaving group may result in having the compounds “hang up” 
in the bottleneck . Regarding the morpholine leaving group performing poorly, it appears the 
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presence of the heterocyclic oxygen in the morpholine leaving group permits interactions with 
Y124, which are demonstrated by these compounds having such a high proportion of their still 
poses between the active site and the bottleneck. 
 
Figure 4.4: Compound A3MN, its unprotonated leaving group, and identification of interactions 
which might facilitate its poor affinity for the active site. 
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4.2 Future Work 
With this larger library, we have shown the tunability of these molecules with regard to 
their affinity for the aged AChE active site. At this point, these results should be passed along to 
our experimental collaborators to focus their synthesis on QMPs with the structural 
characteristics that make binding possible. Additionally, the exploration of other scaffolds, 
namely quinolone and isoquinoline, should be considered. 
 Additionally, QM/MM calculations should be performed on some select QMPs in the 
active site of AChE to determine whether a quinone methide or an intermediate can be generated 
there. This is of significant importance to the project, as all of the computational work thus far 
has been associated with designing QMPs to be specific for the active site and evaluating the 
energetics of QMPs. Starting with QM/MM calculations is part of a progression towards 
determining the actual mechanism of alkylation and beginning design efforts relating to 
alkylation. 
 
